Agalsidase beta Completed Phase N/A Trials for Fabry's Disease

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02969200Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance